To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials
A high quality clinical trial system that is patient-centered and efficient, enabling reliable and timely access to evidence-based therapeutic prevention and treatment options
Major Clinical Trials. CTTI projects focus on regulatory submission clinical trials because of their unique issues and critical importance. Our scope consists of interventional clinical trials including but not limited to, pragmatic clinical trials, cluster randomized trials, clinical trials with historical control arms, delayed start designs, adaptive designs (e.g. Bayesian methods, master protocols), and trials leveraging existing data sources.
Global Partner with a U.S. Perspective. While we may focus on clinical trials from a US perspective, as a global citizen, we recognize that clinical trials are global. We will consider other geographies and collaborate with organizations in those geographies as opportunities arise.
Act in the interest of the public’s health to improve the clinical trial enterprise
Hold paramount the need to protect trial participants
Ensure clinical trials data is of highest quality for decision-making
Value the input and participation of all stakeholders equally